- Home
- LARK vs ALEC Comparison
LARK vs ALEC Comparison
Compare LARK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LARK
- ALEC
- Stock Information
- Founded
- LARK 1885
- ALEC 2013
- Country
- LARK United States
- ALEC United States
- Employees
- LARK N/A
- ALEC N/A
- Industry
- LARK Major Banks
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LARK Finance
- ALEC Health Care
- Exchange
- LARK Nasdaq
- ALEC Nasdaq
- Market Cap
- LARK 150.1M
- ALEC 124.0M
- IPO Year
- LARK N/A
- ALEC 2019
- Fundamental
- Price
- LARK $26.50
- ALEC $1.26
- Analyst Decision
- LARK
- ALEC Hold
- Analyst Count
- LARK 0
- ALEC 9
- Target Price
- LARK N/A
- ALEC $3.40
- AVG Volume (30 Days)
- LARK 6.8K
- ALEC 5.5M
- Earning Date
- LARK 10-29-2025
- ALEC 11-06-2025
- Dividend Yield
- LARK 3.09%
- ALEC N/A
- EPS Growth
- LARK 38.73
- ALEC N/A
- EPS
- LARK 2.98
- ALEC N/A
- Revenue
- LARK $64,367,999.00
- ALEC $69,048,000.00
- Revenue This Year
- LARK N/A
- ALEC N/A
- Revenue Next Year
- LARK N/A
- ALEC $314.69
- P/E Ratio
- LARK $9.06
- ALEC N/A
- Revenue Growth
- LARK 12.95
- ALEC 12.26
- 52 Week Low
- LARK $20.75
- ALEC $0.87
- 52 Week High
- LARK $31.04
- ALEC $5.16
- Technical
- Relative Strength Index (RSI)
- LARK 68.78
- ALEC 32.66
- Support Level
- LARK $25.43
- ALEC $1.19
- Resistance Level
- LARK $26.15
- ALEC $1.60
- Average True Range (ATR)
- LARK 0.47
- ALEC 0.14
- MACD
- LARK 0.18
- ALEC 0.02
- Stochastic Oscillator
- LARK 99.48
- ALEC 15.69
About LARK Landmark Bancorp Inc.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.